Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Expert Review of Anticancer Therapy|April 16, 2024
The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a systematic review and meta-analysisCheng-Long Han, Bao-Wen Tian, Lun-Jie Yan, et al.
Metabolism: Clinical and Experimental|May 25, 2025
Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune responseGuo-Qiang Pan, Yu-Chuan Yan, Rui-Zhe Li, et al.
Expert Review of Gastroenterology & Hepatology|May 6, 2023
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysisHui Liu, Cheng-Long Han, Bao-Wen Tian, et al.
Cancer Cell International|August 31, 2023
MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathwayGuang-Zhen Li, Guang-Xiao Meng, Guo-Qiang Pan, et al.
Biomarker Research|October 4, 2023
A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patientsXin-Cheng Mao, Shuo Shi, Lun-Jie Yan, et al.
Immunotherapy|December 20, 2022
Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysisBao-Wen Tian, Ya-Fei Yang, Chun-Cheng Yang, et al.
Immunotherapy|May 4, 2023
Identification of the most effective subgroup of advanced hepatocellular carcinoma from immune checkpoint blocker treatment: a meta-analysisHui Liu, Chun-Cheng Yang, Yun-Long Ma, et al.
Food & Function|April 22, 2025
An umbrella review of the association between dietary factors and hepatocellular carcinoma riskHan Li, Qi-Hang Cao, Hui Liu, et al.
International Journal of Oncology|April 24, 2014
The PTEN/PI3K/Akt and Wnt/β-catenin signaling pathways are involved in the inhibitory effect of resveratrol on human colon cancer cell proliferationYing-Zi Liu, Ke Wu, Jun Huang, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2023
Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patientsCheng-Long Han, Bao-Wen Tian, Lun-Jie Yan, et al.
Pageof 7